Summary
The Department of Defense denied a security clearance application under Guideline H (Drug Involvement) due to concerns about the applicant's past drug use. The applicant, representing himself, sought to appeal this decision.
However, the Appeal Board affirmed the denial. The Board's review is limited to cases where harmful error by the judge is alleged. In this instance, the applicant did not assert any such error during the appeal process.
Consequently, with no harmful error alleged for the Board to review, the initial denial of the security clearance was upheld.
Conditions Referenced
- H1raisedDrug Involvement
Key Rule Quoted
“The Appeal Board does not review cases de novo.”
Procedural Posture
- SOR issuedJul 10, 2020
- Answer filed—
- Hearing heldJul 5, 2022Decision on the written record.
- Decision dateSep 6, 2022
Cite For
- Affirmation of Denial Due to Lack of Harmful Error Assertion
- Limitations of the Appeal Board's Review Authority
- Guidance on Drug Involvement Under Guideline H